Lilly to Participate in Citi's 17th Annual BioPharma Conference
Eli Lilly and Company (NYSE: LLY) will participate in Citi's 17th Annual BioPharma Conference on September 7, 2022. Daniel Skovronsky, M.D., Ph.D., the company's chief scientific and medical officer, will engage in a fireside chat at 3:30 p.m. ET. A live audio webcast will be accessible via Lilly's Investor website, with a replay available for approximately 90 days.
For over 150 years, Lilly has focused on creating innovative medicines, helping over 47 million people globally. Their ongoing research aims to address critical health challenges, including diabetes, obesity, and Alzheimer's disease.
- None.
- None.
INDIANAPOLIS, Aug. 25, 2022 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will attend Citi's 17th Annual BioPharma Conference on Wednesday, Sept. 7, 2022. Daniel Skovronsky, M.D., Ph.D., Lilly's chief scientific and medical officer, and president of Lilly Research Laboratories, will participate in a fireside chat at 3:30 p.m., Eastern time.
A live audio webcast will be available on the "Webcasts & Presentations" section of Lilly's Investor website at https://investor.lilly.com/webcasts-and-presentations. A replay of the presentation will be available on this same website for approximately 90 days.
About Lilly
Lilly unites caring with discovery to create medicines that make life better for people around the world. We've been pioneering life-changing discoveries for nearly 150 years, and today our medicines help more than 47 million people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges, redefining diabetes care, treating obesity and curtailing its most devastating long-term effects, advancing the fight against Alzheimer's disease, providing solutions to some of the most debilitating immune system disorders, and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we're motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more, visit Lilly.com and Lilly.com/newsroom or follow us on Facebook, Instagram, Twitter and LinkedIn. F-LLY
Refer to: | Jordan Bishop; jordan.bishop@lilly.com; 317-473-5712 (Media) |
Joe Fletcher; jfletcher@lilly.com; 317-296-2884 (Investors) |
View original content to download multimedia:https://www.prnewswire.com/news-releases/lilly-to-participate-in-citis-17th-annual-biopharma-conference-301611971.html
SOURCE Eli Lilly and Company
FAQ
When will Eli Lilly participate in Citi's 17th Annual BioPharma Conference?
Who will represent Eli Lilly at the BioPharma Conference?
What time is Eli Lilly's presentation at the BioPharma Conference?
Where can I watch the Eli Lilly presentation from the BioPharma Conference?
How long will the replay of Eli Lilly's BioPharma Conference presentation be available?
